Solriamfetol, a new treatment for ADHD, showed a 45% reduction in symptoms in a Phase 3 trial. This treatment targets ...

Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension.

Biocon's subsidiary has received approval from the US Food and Drug Administration (US FDA) for its ANDA Norepinephrine ...

This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

Axsome Therapeutics said it's dopamine and norepinephrine reuptake inhibitor solriamfetol (Sunosi), approved for excessive ...

The following is a summary of “Ability of diastolic arterial pressure to better characterize the severity of septic shock ...

Summary: Duloxetine is a balanced selective serotonin and norepinephrine-reuptake inhibitor available in the United States for the treatment of major depressive disorder (MDD) and diabetic ...

Biocon added 1.34% to Rs 348.55 after the company's wholly owned subsidiary Biocon Pharma announced the receipt of U.S Food and Drug Administration (US FDA) approval for its ANDA Norepinephrine ...

KANSAS CITY, Kan., April 03, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing ...

Phthalates — the synthetic chemicals used in everyday products for food packaging, personal care, toys and more — have been ...

Beyond its energizing effects, caffeine can also influence cognitive performance, memory, mood regulation and even long-term ...